Nicola Boffini

Via Olgettina 60
Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Distinctive Inflammatory Traits of Parvovirus B19 Infection Associated with Persisting Autoimmunity.

Distinctive Inflammatory Traits of Parvovirus B19 Infection Associated with Persisting Autoimmunity.

Journal: Viruses

Published: June 04, 2026

Real-world efficacy and retention of guselkumab in psoriatic arthritis: insights from a 12-month multicenter study.

Real-world efficacy and retention of guselkumab in psoriatic arthritis: insights from a 12-month multicenter study.

Journal: ARP rheumatology

Published: October 01, 2025

Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology.

Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology.

Journal: Annals of the rheumatic diseases

Published: June 09, 2025

Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology.

Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology.

Journal: Annals of the rheumatic diseases

Published: June 09, 2025

Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.

Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.

Journal: Scandinavian journal of rheumatology

Published: June 04, 2024

Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease.

Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease.

Journal: Rheumatology international

Published: December 28, 2023

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.

Journal: Arthritis research & therapy

Published: August 05, 2023

Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study.

Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study.

Journal: The Journal of rheumatology

Published: August 01, 2023

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2023

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.

Journal: Frontiers in immunology

Published: March 03, 2021

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.

Journal: The Lancet. Rheumatology

Published: March 03, 2021

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.

Journal: The Lancet. Rheumatology

Published: August 25, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026